With 0.51 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.56 million shares. The 52-week range on ZGN shows that it touched its highest point at $16.36 and its lowest point at $10.12 during that stretch. It currently has a 1-year price target of $15.05. With its current market cap of 3.63 billion, ZGN has annualized dividend of $0.11 while the current yield stands at 0.75%. Beta for the stock currently stands at 0.58.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ZGN was down-trending over the past week, with a drop of -3.14%, but this was up by 3.35% over a month. Three-month performance surged to 25.17% while six-month performance rose 5.91%. The stock gained 9.17% in the past year, while it has gained 25.50% so far this year. A look at the trailing 12-month EPS for ZGN yields 0.36 with Next year EPS estimates of 0.58. For the next quarter, that number is 0.14. This implies an EPS growth rate of 71.32% for this year and 26.00% for next year.
Float and Shares Shorts:
At present, 242.80 million ZGN shares are outstanding with a float of 57.72 million shares on hand for trading. On Feb 29, 2024, short shares totaled 1.77 million, which was 0.71% higher than short shares on Jan 31, 2024. In addition to OGN as the firm’s Organon & Co., ZGEN serves as its The Generation Z ETF.
Institutional Ownership:
Through their ownership of 16.51% of ZGN’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ZGN since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.